Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the section of Clinical Epidemiology Unit at Boston University School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She is an Associate Member of the Spondyloarthritis Research and Treatment Network, and serves on the Education subcommittee, as well as the Early Career Investigator Subcommittee of the American College of Rheumatology.
- Active Staff Hospital Privileges, Rheumatology, Boston Medical Center
- VA Boston Healthcare System
- BU Profile
- Boston Medical Center- Rheumatology Clinic
- BU Rheumatology
- BU Clinical Epidemiology Research and Training Unit
- VA Boston Healthcare System Rheumatology Clinic
- Publications (PubMed)
- SPARTAN (Spondyloarthritis Research and Treatment Network)
- American College of Rheumatology National Meeting Abstracts
- European League Against Rheumatism Meeting Abstracts
- Uveitis study presentation
- University of Connecticut School of Medicine, MD
- Rochester Institute of Technology, BS
- Published on 11/4/2017
Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018 Jan; 77(1):119-123. PMID: 29102956.
- Published on 10/13/2017
Dalal D, Dubreuil M, Peloquin C, Neogi T, Zhang Y, Choi H, Felson D. Meloxicam and risk of myocardial infarction: a population-based nested case-control study. Rheumatol Int. 2017 Dec; 37(12):2071-2078. PMID: 29030657.
- Published on 7/21/2017
Jinno S, Lu N, Jafarzadeh SR, Dubreuil M. Trends in Hospitalizations for Serious Infections in Patients With Rheumatoid Arthritis in the US Between 1993 and 2013. Arthritis Care Res (Hoboken). 2017 Jul 21. PMID: 28732148.
- Published on 7/11/2017
Oza A, Lu N, Schoenfeld SR, Fisher MC, Dubreuil M, Rai SK, Zhang Y, Choi HK. Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study. Ann Rheum Dis. 2017 Oct; 76(10):1737-1742. PMID: 28698231.
- Published on 7/1/2017
Deodhar AA, Kumthekar A, Dubreuil M. Minimal disease activity in axial spondyloarthritis: the need of the hour and a proposal for development. Curr Opin Rheumatol. 2017 Jul; 29(4):293-297. PMID: 28376060.
- Published on 7/1/2017
Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017 Jul; 29(4):317-322. PMID: 28376062.
- Published on 11/1/2016
Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum. 2017 Apr; 46(5):594-600. PMID: 27916277.
- Published on 6/23/2016
Zhang Y, Lu N, Peloquin C, Dubreuil M, Neogi T, Aviña-Zubieta JA, Rai SK, Choi HK. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis. 2017 Feb; 76(2):408-413. PMID: 27338777.
- Published on 6/1/2016
Jinno S, Hasegawa K, Neogi T, Goto T, Dubreuil M. Trends in Emergency Department Visits and Charges for Gout in the United States between 2006 and 2012. J Rheumatol. 2016 Aug; 43(8):1589-92. PMID: 27252429.
- Published on 3/15/2016
Lee T, Lu N, Felson DT, Choi HK, Dalal DS, Zhang Y, Dubreuil M. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study. Rheumatology (Oxford). 2016 Jun; 55(6):1099-105. PMID: 26983451.
View 11 more publications: View full profile at BUMC